How to Get TGA Approval for New Substances in Listed Medicines

How to Get TGA Approval for New Substances in Listed Medicines

TGA approval process for new substances in listed medicinesBringing a new substance into Australia’s listed medicines market can be challenging. The TGA approval for new substances process involves strict regulatory oversight to ensure public safety and product efficacy. If you’re developing a product with a new ingredient, understanding the Therapeutic Goods Administration (TGA) process is critical for a smooth application. 

With the right preparation and expert guidance, you can avoid delays and compliance issues. This guide walks you through the key steps to obtaining approval, from assessing eligibility to ensuring post-approval compliance. 

Understanding the TGA Approval Process 

TGA approval is necessary for any new ingredient that isn’t currently listed under the Australian Register of Therapeutic Goods (ARTG). The process involves a comprehensive assessment of the substance’s safety, quality, and intended use. 

Steps to Obtain TGA Approval for New Substances 

1. Assess Ingredient Eligibility

Before initiating an application, confirm whether your ingredient requires TGA assessment. If the substance isn’t in the ARTG’s permitted list, you’ll need to submit a TGA new substance application. 

2. Gather Essential Documentation

The approval process involves submitting a dossier with: 

  • Safety and toxicological data 
  • Clinical and non-clinical studies 
  • Quality and manufacturing information 
  • Justification for the ingredient’s therapeutic use 

3. Work with Regulatory Experts

Regulatory consultants, such as Quality Smart Solutions, can help streamline the submission process and reduce the likelihood of application rejection. 

4. Submit the Application and Respond to TGA Queries

Once submitted, the TGA may request additional information or clarifications. A well-prepared response can prevent unnecessary delays. 

5. Ensure Post-Approval Compliance

Even after approval, ongoing compliance with Good Manufacturing Practice (GMP) and reporting obligations is required to maintain regulatory standing. 

Avoiding Common Application Challenges 

  • Incomplete or Inaccurate Submissions: Ensure all documentation meets TGA’s stringent requirements. 
  • Lack of Scientific Justification: Supporting data must be robust and align with TGA standards. 
  • Non-Compliance Post-Approval: Failing to meet post-approval obligations can result in product recall or penalties. 

Get Expert Guidance for Your TGA Submission 

Successfully obtaining TGA approval for new substances requires meticulous planning, documentation, and compliance. Partnering with regulatory experts ensures a smoother process and minimizes potential roadblocks. 

If you need support with your application, contact us today to get expert regulatory assistance. 

0/5 (0 Reviews)

About the author

Picture of Andrew Parshad
Andrew Parshad
Andrew Parshad is President, CEO and founder of Quality Smart Solutions, a North American compliance solutions provider offering regulatory and quality assurance services to comply with FDA & Health Canada brands and ingredients regulations in the categories of dietary supplements, foods, cosmetics, OTC drugs and medical devices. Andrew started Quality Smart Solutions in 2007. Since that time he and his firm has served thousands of clients worldwide . Andrew's affiliate company, Quality IMPORT Solutions that offers import agent services into the Canadian market as a government licensed importer for foods, dietary supplements and medical devices.

Subscribe to global regulatory updates

We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.